The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sex is a strong prognostic factor for overall survival in advanced non small cell lung cancer patients and should be considered for survival rates estimations.
 
Miguel Barquin
No Relationships to Disclose
 
Francisco Garcia-Garcia
No Relationships to Disclose
 
Atocha Romero
No Relationships to Disclose
 
Enric Carcereny
No Relationships to Disclose
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
 
Rafael Lopez Castro
Consulting or Advisory Role - Aristo; Boehringer Ingelheim; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche
 
Maria Guirado
No Relationships to Disclose
 
Carlos Camps
Honoraria - Bayer
Consulting or Advisory Role - AstraZeneca
Research Funding - Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD Oncology
 
Joaquim Bosch-Barrera
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pierre Fabre; Roche
 
Bartomeu Massuti
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Janssen; Merck Sharp & Dohme; Roche
 
Ana Laura Ortega
No Relationships to Disclose
 
Jose-Luis Gonzalez-Larriba
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology
Speakers' Bureau - MSD Oncology
Research Funding - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Ignyta; Janssen-Cilag; Mirati Therapeutics; Novartis; OncoMed; Pfizer; PharmaMar; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Takeda
 
Rosario Garcia-Campelo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche; Takeda
 
Manuel Domine
No Relationships to Disclose
 
Sara Agraso Busto
No Relationships to Disclose
 
María Ángeles Sala
No Relationships to Disclose
 
Juana Oramas
No Relationships to Disclose
 
Reyes Bernabé
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Mariano Provencio-Pulla
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche
Research Funding - Boehringer Ingelheim; Pierre Fabre; Roche